登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式(希尔记法):
C22H22N4O4
化学文摘社编号:
分子量:
406.43
UNSPSC Code:
12352107
NACRES:
NA.77
MDL number:
InChI
1S/C22H22N4O4/c1-14-13-25(21(28)15-6-4-3-5-7-15)10-11-26(14)22(29)19(27)16-12-24-20-18(16)17(30-2)8-9-23-20/h3-9,12,14H,10-11,13H2,1-2H3,(H,23,24)/t14-/m1/s1
SMILES string
O=C(N1[C@@H](CN(CC1)C(C2=CC=CC=C2)=O)C)C(C3=CNC4=NC=CC(OC)=C34)=O
InChI key
OKGPFTLYBPQBIX-CQSZACIVSA-N
assay
≥98% (HPLC)
form
powder
color
white to gray
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
Quality Level
General description
BMS-378806 is an indole-based compound that exhibits improved antiviral potency, and pharmaceutical and pharmacokinetic activities. BMS-378806 is inactive against HIV-2 and Simian immunodeficiency virus (SIV) and a few other viruses.
Biochem/physiol Actions
BMS-378806 (BMS-806) is a potent and selective HIV-1 attachment inhibitor that blocks HIV glycoprotein 120 (gp120) from interacting with host T-cell surface glycoprotein CD4 (IC50 = 100 nM against CD4 for binding gp120; CYP1A2/2C9/2C19/2D6/3A4 IC50 >23 μM) without affecting HIV integrase, protease, or reverse transcriptase activity. BMS-806 effectively prevents various HIV-1 isolates from replication (EC50 from 0.85 to 26.5 nM in MT-2 and PM1 cultures; host cytotoxicity IC50 >300 μM) without affecting HIV-2, SIV, MuLV, RSV, HCMV, BVDV, VSV, or influenza virus.
Potent and selective HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions and protects against HIV-1 infection in host cultures.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Quantitative determination of BMS-378806 in human plasma and urine by high-performance liquid chromatography/tandem mass spectrometry
Y.-J. Xue, et al.
Journal of Separation Science (2007)
Tao Wang et al.
Journal of medicinal chemistry, 46(20), 4236-4239 (2003-09-19)
Indole derivative 1 interferes with the interaction of the HIV surface protein gp120 with the host cell receptor CD4. The 4-fluoro derivative 2 exhibited markedly enhanced potency and was bioavailable in the rat, dog, and cynomolgus monkey when administered orally
Shitao Zou et al.
Journal of virology, 94(10) (2020-03-13)
During human immunodeficiency virus type 1 (HIV-1) entry into cells, the viral envelope glycoprotein (Env) trimer [(gp120/gp41)3] binds the receptors CD4 and CCR5 and fuses the viral and cell membranes. CD4 binding changes Env from a pretriggered (state-1) conformation to
Prediction of the binding mode between BMS-378806 and HIV-1 gp120 by docking and molecular dynamics simulation
Ren K, et al.
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, 766-772 (2006)
A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding
Pin-Fang Lin, et al.
Proceedings of the National Science Council, Republic of China / Applied Science, 100(19), 11013-11018 (2003)
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持